chromosome

trends & perspectives in clinical research

goBalto Chromosome

goBalto Study Startup Summit Attracts Leading Pharmaceutical and CRO Organizations

by Craig Morgan
17Oct2016

Engagement reflects adoption of industry proven study startup solutions.

goBalto Autumn 2016 Study Startup Summit

goBalto would like to thank the leading Pharmaceutical and CRO organizations that particapated in our autumn Study Startup Summit, held in Philadelphia, October 11 - 12.

The summit, a biannual event, explored how goBalto's award winning suite of study startup applications are continuing to evolve to help clinical research professionals transform their existing business processes, including best practices and case studies. Multiple organizations presented about their goBalto implementations, results and key learnings to further enhance study startup optimization.

Jennifer Evola
JENNIFER EVOLA
Senior Regulatory Documents Specialist
Allergan
"goBalto's Study Startup Summit far exceeded my expectations. Not only was I able to gain valuable insight from listening to the experiences of other clients, but I was also able to gain a clear view of goBalto's direction and the possibilities their goals will create for my company's study startup business needs."

goBalto's CEO, Sujay Jadhav, opened the summit with a keynote address highlighting the industry trends in study startup, growing market adoption by the industry, evolution of goBalto's study startup platform and future technology vision.

Sujay Jadhav
SUJAY JADHAV
CEO
goBalto
"Our industry proven end-to-end study startup methodology, spanning site identification, feasibility assessment, selection through to activation, with comprehensive metrics, aligns with the goal of faster development by significantly impacting cycle times. This leads to greater cost savings, mitigates rescue studies, and leads to faster market entry. Ultimately, achieving the goal of speeding the delivery of valuable therapies to patients sooner."

With recent multiple enterprise and global expansions goBalto now services three of the top 5 CROs and more than two-thirds of the top 25 pharmas, managing their clinical trial documents globally, representing more than 85 percent of clinical trial sites in phase II & III of the top 20 pharma companies.

Christine Pierre
CHRISTINE PIERRE
President
SCRS
"Investigative sites are the lifeblood of clinical trials. As such, the deployment of technology that can help sites facilitate collaboration and communications with sponsors and CROs is critical. It is pleasing to see the evolution of tools that continue to enhance and streamline this effort."

Christine was a industry keynote speaker at the goBalto Study Startup Summit

With over 35,000 investigative sites in more than 60 countries using goBalto Activate, our flagship product, to manage, track, and complete study startup tasks, goBalto has the largest industry-proven set of country specific regulatory business process workflows.

According to Jadhav, "The maturity of our solution is having a significant impact, delivering tangible operating results, allowing companies to dramatically improve their study startup operations. Multiple customers including global CROs and large multinational pharmaceutical companies have reported an over 30 percentage reduction in cycle time for sites managed in Activate. We are the only vendor capable of delivering consistent cycle time savings, and it is this field tested validation that customers are seeking."

Registration for the goBalto Study Startup Summit is complimentary for goBalto customers and invited guests. To learn more or register for the spring summit to be held in New York, March 8 - 9, please contact us.

See how you can accelerate your clinical trials—request a FREE demonstration today.

Recent Posts